NutraFuels, Inc. (NTFU) Announces Further Steps for Initiation of Clinical Trials with the Company's Product Line of Oral Spray Nutraceuticals

COCONUT CREEK, FL--(Marketwired - February 23, 2017) - NutraFuels, Inc. ("NutraFuels" or "NTFU"), (OTC PINK: NTFU), today announced that the company as part of the implementation of initiation of clinical studies on the company's product line of oral spray nutraceuticals has announced the appointment of Kenneth Duchin, Ph.D. as Vice-President Clinical Development and the agreement with Palm Beach Research to conduct clinical studies.

The recent growth of NutraFuels has provided the opportunity to explore the benefits of the oral spray product line. Dr Duchin's career has spanned over 30 years in the pharmaceutical industry in various management positions at Bristol-Myers Squibb and in small and mid-size companies (Theravance, IVAX Corporation, Noven Pharmaceuticals) as well as in start-up virtual organizations. He has extensive drug development experience in a broad range of therapeutic areas, has led several registration programs, authored regulatory NDA and ANDA documents and has led cross-functional development teams. In addition, he has been an inventor of 9 patents and has published nearly 40 papers in peer reviewed journals.

To facilitate the clinical investigations sponsored by Nutrafuels, the company has engaged Palm Beach Research, West Palm Beach FL to conduct the clinical studies. This facility has access to large numbers of patients who routinely participate in clinical trials for many pharmaceutical and biotech companies based in the US and abroad.

"We are very pleased to be working with Ken and Palm Beach Research to initiate clinical trials for our health and wellness products," said Edgar Ward, NutraFuels President/CEO.

About Palm Beach Research Center

Since 1994, Palm Beach Research Center has been dedicated to advancing the development of new investigational treatments (drugs, devices) to benefit mankind by assisting pharmaceutical companies in research and eventual FDA approval for public availability. Our experienced research team is designed to streamline efforts to assure maximum efficiency.

Palm Beach Research Center is located in its own building, on the corner of Palm Beach Lakes Boulevard and Okeechobee Boulevard, just west of I-95. The center is almost 7,000 square feet of dedicated research space. There are separate branches for patient recruitment, regulatory, quality assurance, and patient screening in addition to eight full time, clinical research coordinators.